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Abstract
Background: The ABCC5 gene encodes an organic anion pump of the ATP-binding cassette
(ABC) transporter family, subclass C. The exact physiological function of ABCC5 however is not
known. Here, we have isolated three novel ABCC5 splice variants and characterized their role in
the regulation of ABCC5 gene expression.
Results: Two additional exons within intron 5 of the ABCC5 gene were identified; one of the
exons exhibits alternative donor splice sites. Differential usage of these exons generates three
short ABCC5 transcripts named ABCC5_SV1, ABCC5_SV2 and ABCC5_SV3. The variants share
the first five exons with the ABCC5 gene but differ in their 3' sequences. ABCC5 and its novel
isoforms are abundantly expressed in the human retina. Splice variant ABCC5_SV1 and
ABCC5_SV2 contain premature stop codons. While inhibition of nonsense-mediated mRNA decay
selectively stabilized ABCC5_SV1 but not ABCC5_SV2, the amount of full length ABCC5 mRNA
was simultaneously reduced. A negative regulatory effect on full length ABCC5 expression was also
observed when the ABCC5 isoforms were silenced with siRNA duplexes. Finally, we show that the
evolutionarily conserved ABCC5_SV2 transcript is translated into a protein abundantly present in
endothelial cells of inner retinal blood vessels and along RPE membranes.
Conclusion:  Our data suggest that alternative splicing of the ABCC5 gene has functional
consequences by modulating ABCC5 gene expression. In addition, at least one ABCC5 splice
variant is protein-coding and produces a truncated ABCC5 protein isoform with thus far unknown
functional properties in the retina.
Background
ATP-binding cassette (ABC) transporters are integral
membrane proteins which mediate the ATP-dependent
translocation of a wide variety of compounds across extra-
and intracellular membranes [1]. The substrate diversity
ranges from small inorganic ions, amino acids, peptides,
sugars, lipids, and anticancer drugs to large proteins. ABC
transporters are characterized by a basic modular architec-
ture consisting of two membrane spanning segments and
two intracellular nucleotide binding domains with
Walker motifs A and B and an ATP-binding cassette signa-
ture [1].
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Based on protein sequence homology and phylogenetic
analyses, the 56 mammalian ABC transporters have been
classified into seven subfamilies with the closely related
multidrug resistance proteins (MRPs) grouped together in
the C branch of ABC proteins (ABCC). ABCC5 (MRP5) is
a typical organic anion pump and belongs to the short
type of ABCC proteins which differ from the long type by
the lack of an N-terminal transmembrane domain [2]. In
vitro  transport studies identified ABCC5 as a cellular
export pump for numerous compounds including cGMP
[3], nucleoside monophosphate analogs [e. g. [4,5]],
heavy metal compounds and fluorochromes [6]. ABCC5-
transfected cells were also reported to exhibit resistance to
anticancer and antiviral drugs [5,7]. The affinity of ABCC5
to its substrates, however, has generally been low. This
suggests that the biological significance of ABCC5 as a
mediator of active cGMP efflux, its possible role in drug
resistance and ultimately its physiological function is still
unknown.
Previous mRNA expression studies showed that the
ABCC5 gene is widely transcribed among human tissues
with highest levels in heart, brain, skeletal muscle, kidney
and testis [6,8]. Multiple mRNA species for various ABCC
family members have been described [9,10] including the
ABCC5 locus [6]. Sequencing of a single cDNA clone from
a human lung cancer cell line identified a splice variant of
ABCC5 formed by the alternative usage of a cryptic donor
splice site upstream of exon 11 [11]. This so-called short
type of multidrug resistance protein homologue (SMRP)
translates into an N-terminally truncated version of
ABCC5 (946 versus 1437 amino acids) and shows a simi-
lar expression pattern as the full length ABCC5 transcript
[12]. The physiological relevance of the rare SMRP tran-
script is not known.
In this study we have characterized three novel isoforms
of the ABCC5 gene generated by alternative splicing of
newly identified exons within intron 5 of the ABCC5
gene. The various ABCC5 transcripts are abundantly
expressed in the human retina but are also present in
many other tissues at varying levels. We provide evidence
that alternative splicing of the ABCC5 mRNA may provide
an elegant mechanism to achieve a tissue-dependant reg-
ulation of ABCC5 gene expression.
Results
Cloning of three novel ABCC5 isoforms
Large-scale sequencing of a human retinal cDNA library
[13] revealed two small cDNA clones, 6D2F (160 bp) and
A06-Ret7 (171 bp), located within intron 5 of the ABCC5
gene (Fig. 1A). Subsequent BlastN database queries [14]
revealed the retinal sequences to correspond to the 3' end
of three overlapping full length cDNA clones isolated
from cancer cells and placenta [GenBank: BC050744,
CR590924 and CR619835]. After assembly, the human
mRNA sequences from GenBank comprise the first five
exons of the ABCC5 gene spliced to two alternative exons
within intron 5 of the ABCC5 gene, named exon 5A and
5B (Fig. 1A). To further explore the existence of novel
ABCC5 splice variants in retina, we performed RT-PCR on
human retinal RNA with primers located in exon 5 and
exon 5B. Three distinct PCR products of 203, 275 and 353
base pairs (bp) were repeatedly amplified (Fig. 1B). Direct
sequencing of the PCR products showed that the two
smaller fragments differ by the inclusion of exon 5A. In
addition, the usage of an alternative splice donor
sequence produces a larger exon 5A (termed exon 5Aa)
giving rise to the 353 bp fragment (Fig. 1B). RT-PCR with
primers located in exon 5 (F1) and exon 6 (R1) amplified
a single 267 bp fragment lacking exon 5A, 5Aa or 5B (data
not shown) indicating that the newly identified exonic
sequences represent the respective 3'-ends of novel
ABCC5 splice variants ABCC5_SV1 (2010 bp) [Gen-
Bank:AY754874], ABCC5_SV2 (1933 bp) [Gen-
Bank:AY754875] and ABCC5_SV3 (1858 bp)
[GenBank:AY754876] (Fig. 1B). This is confirmed by the
presence of a potential consensus polyadenylation signal,
AATAAA, within 15 bases of the 3' end of exon 5B. Trans-
lation of the putative ABCC5_SV1, ABCC5_SV2 and
ABCC5_SV3 mRNA sequences revealed stop codons in
exon 5Aa, exon 5A and exon 5B, respectively (Fig. 1B).
This should lead to putative truncated ABCC5 proteins
which share the 197 N-terminal amino acids with the full
length ABCC5 transporter and terminate in short distinct
C-termini of 15 (ABCC5_SV1), 11 (ABCC5_SV2) and 28
(ABCC5_SV3) amino acids in length.
Nucleotide homology searches using the novel ABCC5
exons as templates showed that the sequence and the
flanking splice junctions of exon 5A are highly conserved
between mammalian species (e.g. 100% sequence iden-
tity to monkey/cow and 98% identity to mouse/dog).
Analysis of EST sequences from different species con-
firmed that exon 5A is commonly spliced to exon 5
whereas each species uses different donor splice sites to
join exon 5A to downstream sequences within intron 5 of
the ABCC5 gene. Thus, sequences overlapping but not
identical to human exon 5B are frequently included in
alternative transcripts. The presence of ABCC5 splice vari-
ants with additional exons within intron 5 of the ABCC5
gene appears to be a common feature among mammalian
species possibly indicating a conserved function of these
molecules.
Expression analysis
Qualitative RT-PCR analysis revealed varying transcrip-
tion levels of the novel splice variants in human retina
with an increase of expression from ABCC5_SV1 to
ABCC5_SV3 (Fig. 1B). The tissue distribution of the novelBMC Molecular Biology 2007, 8:42 http://www.biomedcentral.com/1471-2199/8/42
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ABCC5 splice variants was studied by virtual Northern
blot analysis with a radiolabeled probe representing exon
5B. A single strong band of approximately 2.0 kb was
detected exclusively in retina but not in bladder, heart,
lung, skeletal muscle and RPE (Fig. 2A). To further inves-
tigate the relative expression of the splice variants, quanti-
tative real-time RT-PCR (qRT-PCR) with primer pairs
specific for each of the ABCC5 transcripts was performed
with RNA extracted from ten human tissues including
samples from three distinct brain areas (Fig. 2B). An over-
all abundant expression of ABCC5 and the shorter ABCC5
isoforms was observed in human neural retina. In addi-
tion, full length ABCC5 is expressed at moderate levels in
several tissues including brain, RPE, bladder and heart. A
relatively high expression in RPE, bladder and stomach
was found for ABCC5_SV2 whereas ABCC5_SV1 and
ABCC5_SV3 are only weakly present in nonneuronal tis-
sues. Moderate expression of ABCC5_SV1 and
ABCC5_SV3 was detected in cerebellum. Taken together,
our data show that each tissue analyzed expresses the var-
ious ABCC5 transcripts but at distinct levels suggesting a
complex regulation of gene expression.
Nonsense mediated decay of ABCC5 isoforms
A stop codon which resides over 50–55 nucleotides
upstream from a downstream exon/exon junction is pre-
dicted to be recognized by the translational machinery as
a premature termination codon (PTC) and thus should be
targeted by nonsense mediated mRNA decay (NMD) [15].
Splice variant ABCC5_SV1 contains a stop codon 104 bp
upstream of the exon 5Aa/5B splice junction fulfilling the
criteria for a PTC. To determine whether the ABCC5_SV1
mRNA is subject to NMD we inactivated the NMD surveil-
lance mechanism by the addition of translation inhibitors
puromycin, or alternatively anisomycin, [16] to human
cell lines ARPE-19 and Y79 which were shown before to
express ABCC5, ABCC5_SV1, ABCC5_SV2 and
ABCC5_SV3 (data not shown). By qRT-PCR, puromycin
treatment drastically increased the relative expression of
ABCC5_SV1 mRNA by almost 3-fold in the ARPE-19 cell
Cloning of ABCC5 splice variants Figure 1
Cloning of ABCC5 splice variants. (A) Identification of exon 5A, 5Aa and 5B within intron 5 of the ABCC5 gene. Exons of 
the ABCC5 gene are shown as open boxes, the retinal cDNA fragments as solid boxes. The mRNAGenBank represents a cDNA 
assembled from three human mRNA sequences deposited in GenBank [BC050744, CR590924 and CR619835]. The locations 
of primers used to PCR amplify ABCC5 cDNA fragments and the start and stop codon of full length ABCC5 are indicated by 
solid triangles above. Numbers refer to the respective exon number. The vertical line in exon 5Aa indicates an alternative 
splice donor site (B) Differential splicing of exons 5A, 5Aa and 5B generates three ABCC5 isoforms in the human retina, 
termed ABCC5_SV1, ABCC5_SV2 and ABCC5_SV3. RNA from human retina was RT-PCR amplified with primer pair F1/R3.
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line and by more than 2-fold in the Y79 cell line (Fig. 3).
Interestingly, in both cell lines the expression of the
ABCC5 transcript decreased by a factor of approximately
two. In contrast, the relative expression levels of
ABCC5_SV2 and ABCC5_SV3 remained unaffected by the
addition of the translation inhibitors. The concentration
of the mRNAs largely returned to pre-treatment levels after
protein synthesis was restored by removing puromycin
from the media. Similar to the treatment with puromycin,
application of anisomycin lead to a 2- and 4-fold increase
of ABCC5_SV1 mRNA in Y79 and ARPE-19 cells, respec-
tively, whereas the levels of the remaining ABCC5 tran-
script variants were stable (ABCC5_SV2 and ABCC5_SV3)
or decreased (ABCC5) (data not shown). Together, these
data demonstrate that inhibition of cellular protein syn-
thesis leads to a selective stabilization of the ABCC5_SV1
mRNA indicating that this transcript is regulated by NMD.
In addition, elevated levels of ABCC5_SV1 mRNA appear
to regulate ABCC5 gene expression without exerting any
effects on the remaining short ABCC5 isoforms.
Silencing of the novel ABCC5 isoforms by RNA 
interference
To further investigate whether the expression of the vari-
ous ABCC5 transcripts may be co-regulated, ABCC5_SV1,
ABCC5_SV2 and ABCC5_SV3 were silenced by RNA inter-
ference. Consequently, treatment of ARPE-19 cells with an
siRNA probe targeted to exon 5B (siRNA.1) decreased the
expression of ABCC5_SV1, ABCC5_SV2 and ABCC5_SV3
up to 80% while the expression of ABCC5 increased 1.5-
fold over time (Fig. 4A). A similar rise in ABCC5 expres-
sion was observed when ABCC5_SV1 and ABCC5_SV2
expression was selectively suppressed by siRNA.2 (Fig.
4B). The level of ABCC5_SV3 essentially remained unaf-
fected. siRNA probes to specifically target ABCC5_SV1
without affecting the other two isoforms were designed,
but consistently failed to reveal a measurable knock down
effect of ABCC5_SV1 expression (data not shown). From
our results we conclude that ABCC5 mRNA expression is
differentially regulated by the presence of one or more
short ABCC5 splice variants, most likely by ABCC5_SV1
and/or ABCC5_SV2.
Expression analysis of ABCC5 splice variants Figure 2
Expression analysis of ABCC5 splice variants. (A) Virtual Northern blot probed with an RT-PCR fragment originated 
from exon 5B. Consequently, the 2 kb signal obtained in retina represents transcripts ABCC5_SV1, ABCC5_SV2 and 
ABCC5_SV3. (B) qRT-PCR expression analysis of full length ABCC5 and the three splice variants. The expression values for 
each transcript in the various tissues are indicated by bars in different shades and are given relative to the expression in retina 
which was set to 100%.
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Localization of ABCC5_SV2 in the retina
The most C-terminal 11 amino acid peptide specifically
encoded by the ABCC5_SV2 isoform appears highly con-
served in a number of mammalian species suggesting a
functional constraint on this sequence (Fig. 5A). To inves-
tigate whether ABCC5_SV2 indeed is expressed as a short
ABCC5 protein isoform, we generated polyclonal anti-
bodies (SV2-304) directed against its unique 11 amino
acid terminus. Immunofluorescence labeling of frozen
mouse retinal sections with purified SV2-304 antibodies
repeatedly produced strong staining of endothelial cells of
the inner retinal capillaries (Fig. 5B, arrows). Weaker but
distinct labelling was also observed in the synapses of the
outer plexiform layer and the photoreceptor outer seg-
ments. Preadsorption of SV2-304 with GST-ABCC5_SV2
fusion protein completely abolished the immunostaining
in the mouse retina (Fig. 5C) indicating that the labelling
is specific. In the RPE, a tissue with high ABCC5_SV2 tran-
scription (Fig. 2B), SV2-304 antibodies produced mark-
edly staining of the apical and basolateral surfaces with
exclusion of the RPE microvilli (Fig. 5E).
Discussion
Here we characterize three short ABCC5 splice variants
which consist of sequences corresponding to the first 5
exons of the ABCC5 gene but revealing distinct 3' ends.
The isoforms are generated by the inclusion of one or two
novel exons within intron 5 of the ABCC5 gene and the
alternative usage of donor splice sites in one of these
exons. In-frame translation of the additional exons intro-
duces stop codons, thus generating unique C-termini.
Quantitative real time RT-PCR analysis demonstrates that
both, the full length ABCC5 transcript and the shorter
ABCC5 splice variants are present at varying levels in a
number of tissues while all are predominantly expressed
in the human retina. Although ABCC5 mRNA expression
has repeatedly been found in neurons of the CNS [6,8],
this is the first report of ABCC5 being expressed in the
neurosensory retina. ABCC5 can therefore be added to the
list of abundant ABC transporters with a function in the
eye which for example includes ABCA4, the gene underly-
ing Stargardt's disease [17] and ABCC6, the gene impli-
cated in pseudoxanthoma elasticum [18,19]. So far, a role
for ABCC5 in retinal disease has not been determined.
Genome-wide analyses have led to the suggestion that
alternative splicing affects the vast majority of genes in
many organisms [20,21]. EST-based studies indicated a
particularly high level of alternative splicing in neuronal
tissues including the retina [22]. The high fraction of
splice variants among retinal cDNAs are reflected in
numerous reports of alternatively spliced retinal genes [e.
g. [13,23]]. Moreover, retina-specific mRNA processing
has been reported for genes with a broader tissue distribu-
tion [24,25]. The retina is a multilayered tissue composed
of a number of distinct cell types that are specialized in
their function to transform light energy into electric sig-
nals. Alternative splicing is regarded an important mecha-
nism to create protein diversity but also to regulate gene
expression [26]. Both processes may well be required to
perform and control the complex phototransduction
process in the retina and also to establish and maintain
the structure and integrity of this unique and highly
evolved tissue.
Our results on the functional role of alternatively spliced
products of the ABCC5 gene in the retina demonstrate
that one isoform, ABCC5_SV1, is a target for NMD. NMD
is a post-transcriptional surveillance mechanism in
Inhibition of protein synthesis selectively stabilizes  ABCC5_SV1 mRNA Figure 3
Inhibition of protein synthesis selectively stabilizes 
ABCC5_SV1 mRNA. Total RNA was isolated from 
untreated ARPE-19 and Y79 cells, from cells exposed to 
puromycin and from cells grown in regular medium after 
antibiotic exposure (post-puromycin). The RNAs were sub-
jected to qRT-PCR using primer pairs specific for the 
ABCC5 splice variants. The expression values for each vari-
ant are depicted by different symbols and are given relative 
to the expression in untreated cells which was set to 100%. 
Error bars denote standard deviations of reactions per-
formed independently in triplicate.
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eukaryotic cells used to eliminate newly synthesized
mRNAs containing premature termination codons (PTCs)
[15,27]. NMD targets which may be generated by muta-
tions or errors in mRNA processing are potentially harm-
ful and need to be cleared. In contrast, alternative splicing
to induce NMD is a widely used mechanism for gene reg-
ulation, also known as regulated unproductive splicing
and translation (RUST) [28]. Our data obtained from
NMD inactivation and confirmed by RNA interference
show that the expression level of full length ABCC5 tran-
script is influenced by the presence of alternatively spliced
ABCC5 isoforms, in particular ABCC5_SV1. RUST there-
fore may play a role in ABCC5 gene regulation.
Alternative splicing of genes encoding ABC transporters
has previously been reported [9,10,29]. Noticeably, alter-
native splicing of two evolutionarily conserved PTC-con-
taining exons of the ABCC4 gene produces mRNAs that
are degraded by NMD [10]. Regulation of ABCC4 gene
expression is thought to be accomplished by facilitating
the re-initiation of translation. As a consequence shorter
ABCC4 proteins lacking a potentially important amino-
terminal linker domain would be generated.
The newly identified ABCC5 splice variants encode puta-
tive proteins with isoform-specific C-termini that are pre-
dicted to be cytosolic. We have generated an antiserum
directed against the conserved ABCC5_SV2 isoform which
specifically labels the endothelial cells of blood vessels in
the inner mouse retina as well as apical and basolateral
surfaces of the RPE. This indicates that in addition to gene
regulation, alternative splicing of the ABCC5 gene may be
a mechanism to increase protein diversity. A polyclonal
antibody directed against the C-terminus of the ABCC5
transporter has been widely used to determine the tissue
distribution of ABCC5 in several organs. Among other cell
types, this antibody strongly stains capillary endothelial
cells in the genitourinary tract [30], in the heart [31] and
in the brain [32]. In brain, a contribution of ABC trans-
porters including ABCC5 to the blood-brain barrier is dis-
cussed [32]. Similarly, the ABCC5_SV2 isoform could play
a role in the inner and outer blood-retinal barrier function
possibly by controlling ABCC5 transporter activity.
Conclusion
Here we show that alternative splicing plays a role in the
regulation of ABCC5 gene expression via NMD-related
mechanisms. In addition, we present evidence that at least
one of the ABCC5 splice variants encodes a functional
protein localized to the endothelial cells of the inner reti-
nal blood supply and along RPE membranes. Further
studies are needed to determine the precise function of
ABCC5 and its regulatory as well as protein-encoding iso-
forms in the retina. This may also shed light onto a possi-
ble contribution of ABCC5 to retinal disease.
Methods
cDNA cloning
Oligonucleotide primers F1 (5'-AGA AGA GCT GAA TGA
AGT TG-3'), R1 (5'-TTC AAT GCC CAA GTC AGT G-3'), R
(5'-AGC CAT CTA ACA GGT CAT C-3') and R3 (5'-TCA
GTA AGA TGG CGG TGC AGT-3') were used to RT-PCR
amplify ABCC5 cDNA fragments from human retina (Fig.
1A). The PCR products were directly sequenced utilizing
the ABI PRISM Ready Reaction Sequencing Kit and the ABI
310 automated sequencer (PerkinElmer Life Sciences
GmbH).
Expression analysis
For virtual Northern blot analysis full-length double
stranded cDNA was synthesized from 3 μg of total RNA
using the SMART cDNA Library Construction Kit (BD Bio-
Suppression of ABCC5 splice variants by RNA interference  increases full length ABCC5 mRNA expression Figure 4
Suppression of ABCC5 splice variants by RNA inter-
ference increases full length ABCC5 mRNA expres-
sion. ARPE-19 cells were transfected with siRNA.1 targeting 
ABCC5_SV1, ABCC5_SV2 and ABCC5_SV3 or siRNA.2 tar-
geting ABCC5_SV1 and ABCC5_SV2. ARPE-19 transfected 
with a nonsense siRNA was used as a negative control. Total 
RNA isolated 8 h, 24 h and 48 h after transfection was used 
for qRT-PCR analysis. The respective expression values are 
shown by specific symbols. The expression level of cells 
transfected with nonsense siRNA was set at 100%. Bar 
graphs represent standard deviations of reactions performed 
in triplicate.
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sciences Clontech) according to the supplier's instruc-
tions. Amplification was performed in 19–22 cycles. The
cDNAs were separated electrophoretically and transferred
to Hybond N+ membrane. A 362 bp DNA fragment from
exon 5B of ABCC5 was obtained by RT-PCR amplification
with primer pair F (5'-GAA AGA CCC AGA AGG ATG-3')/
R and was [α-32P]-dCTP radiolabeled to be used as a probe
for filter hybridization at 58°C. The filter was exposed at -
80°C for 3 days.
The human total RNA master panel including RNAs from
21 different human tissues was purchased from BD Bio-
sciences. RNA from post-mortem retina and retinal pig-
ment epithelium (RPE) was isolated using the RNeasy
Total RNA System Kit (Qiagen). First-strand cDNA was
generated from RNA samples by reverse transcription
using Superscript II (Invitrogen) and served as a template
for subsequent PCR assays. Real-time quantitative RT-PCR
(qRT-PCR) was performed as described previously
(Krämer et al., 2004). Primer pairs for qRT-PCR analysis
and fragment sizes were as follows: ABCC5_SV1 (5'-CAA
GAA GAG CTG AAT GAA GT-3' and 5'-ACA GCA CCA
AGC AAG TGG TC-3', 147 bp), ABCC5_SV2 (5'-GGC AAG
AAG AGC TGA ATG AAG T-3' and 5'-CAG CCA TCC TGA
AAA TTT GGT-3', 151 bp), ABCC5_SV3 (5'-GGC AAG
AAG AGC TGA ATG AAG T-3'and 5'-CAG TCT CCA AAG
GAA GGT GGT-3', 151 bp). Average normalization factors
were calculated based on four human housekeeping genes
(B2M, TBP, SDHA and HPRT) which displayed a stable
expression in all tissues. These factors were then used to
determine the relative normalized expression values of
the ABCC5 transcript variants. All samples were analyzed
in triplicate.
Inhibition of protein synthesis
The RPE cell line ARPE-19 was cultured in DMEM/Ham's
F12 (1:1 mixture) supplemented with 2 mM L-glutamine,
15 mM HEPES, 42 mM NaHCO3 and 10% FCS. The retin-
oblastoma cell line Y79 was grown in DMEM containing
10% FCS. In both cell lines protein synthesis was inhib-
ited by addition of 100 μg/ml puromycin or 100 μg/ml
anisomycin (Invitrogen) for 2 hours. The cells were
washed with PBS and transferred to medium without anti-
biotics for another 4 hours. Total RNA was then extracted
as described above.
RNA interference
The siRNA duplexes (HPP grade) were purchased from
Qiagen. The siRNA.1 was designed to target sequence 5'-
AAT TCA GCG TAG CTA CCT CCA-3' and siRNA.2 to tar-
get sequence 5'-AAT CTC TCG CCA AGA GTT CAG-3'. A
non-targeting siRNA (5'-AAT TCT CCG AAC GTG TCA
CGT-3') was used as a control. Cells were seeded in 6-well
plates at a density of 1 × 106 cells/well 24 hours prior to
transfection. Transfections were performed with 2 μg
siRNA per well using the TransMessenger Transfection
Reagent (Qiagen) following the manufacturer's sugges-
tions. Total RNA isolated from the cells at 8, 24 and 48
hours after transfection was subjected to qRT-PCR.
Immunohistochemistry
An ABCC5_SV2 antiserum (SV2_304) was generated by
immunizing rabbits with a GST-ABCC5_SV2 fusion pro-
tein containing the unique 11 C-terminal amino acids.
The polyclonal antibodies were affinity-purified using a
Localization of the ABCC5_SV2 protein in mouse retina Figure 5
Localization of the ABCC5_SV2 protein in mouse 
retina. (A) Alignment of the immediate C-termini of putative 
ABCC5_SV2 proteins from several mammalian species 
reveals 100% amino acid identity. The relative location of the 
exon 5 – exon 5A boundary is shown by a vertical bar. (B) 
Differential interference contrast (DIC) image shows the var-
ious retinal cell layers: OS, outer segments; IS, inner seg-
ments; ONL, outer nuclear layer; OPL, outer plexiform 
layer; INL, inner nuclear layer; IPL, inner plexiform layer; 
GCL; ganglion cell layer. (C) ABCC5_SV2 immunolabeling of 
frozen mouse retina sections with the SV2-304 antibody. 
Arrows point to labelled endothelial cells of the inner retinal 
blood vessels. (D) Mouse retinal section stained with SV2-
304 antibodies preincubated with an excess of competing 
GST-ABCC5_SV2 peptide. (E) RPE monolayer labelled with 
SV2-304 antibodies (green), the nuclei were counterstained 
with DAPI (blue). The basal side of the RPE is oriented 
towards the top.
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()HiTrap NHS-activated sepharose HP column (Amer-
sham Biosciences). Mouse posterior eyecups were immer-
sion-fixed in 4% paraformaldeyde in 0.1 M phosphate
buffer (PB [pH 7.4]) for 1 hour and cryoprotected in 0.1
M PB containing 18% sucrose for 4 h. The eyecups were
embedded in OCT embedding medium (Tissue-Tek), fast
frozen in liquid nitrogen and cryosectioned vertically at
10 μm. Cryosections were blocked with 0.1 M PB contain-
ing 0.3% Triton X-100 and 10% goat serum for 30 min-
utes and labeled for 12 hours with SV2_304 diluted 1:100
in 0.1 M PB, 0.1% Triton X-100 and 2.5% goat serum at
room temperature. After washing in 0.1 M PB, the sections
were incubated with the secondary antibody goat anti-
rabbit IgG conjugated to Alexa 488 (Invitrogen) diluted
1:800 for 1 h. Labeled sections were washed in 0.1 M PB,
mounted (Confocal Matrix) and examined under an Axi-
oskop-2 mot plus fluorescence microscope (Zeiss). To
evaluate the specificity of the SV2_304 antibody, 100 μl of
diluted purified antibody was preadsorbed for 4 hours
with 100 μg of GST-ABCC5_SV2 fusion protein immobi-
lized on glutathione sepharose beads. The beads were pel-
leted at 1000 × g for 3 minutes and the supernatants were
used for immunohistochemistry as described above.
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